Class II

Drug Recall: Carbamazepine Tablets, USP, 200mg, 1000 count bottles, Rx only, Manufactured by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Distributed by: Taro Pharmaceuticals USA, Inc., Hawthor

SUN PHARMACEUTICAL INDUSTRIES INC · August 3, 2026

Reason for Recall

CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing

Product Description

Carbamazepine Tablets, USP, 200mg, 1000 count bottles, Rx only, Manufactured by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Distributed by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC 51672-4005-3.

Distribution

US Nationwide.

States Affected

NATIONWIDE

Quantity Affected

1968 Bottles (1000Tablets/Bottle)

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0770-2026

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.